Etropal AD operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Etropal AD with three other
medical equipment manufacturers in Europe:
Safe Orthopaedics SAS
sales of 3.11 million Euro [US$3.52 million]
(1.48 million Euro [US$1.67 million]
Pixium Vision Sa
based in France
(2.54 million Euro [US$2.87 million]
During the year ended December of 2017, sales at
Etropal AD were 7.40 million Bulgarian Lev (US$4.28 million).
increase of 10.4%
versus 2016, when the company's sales were 6.70 million Bulgarian Lev.
Despite this increase, sales are still
below the level achieved in 2015, when Etropal AD
reported sales of 7.91 million Bulgarian Lev.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Etropal AD had sales
of 7.80 million Bulgarian Lev.